#discovery - Techseriesinsight

Lucid_Origin_A_futuristic_digital_landscape_showing_a_glowing__0

September 4, 2025
tsi_admin
Insights

Understanding Customer Journey Mapping & the Role of MarTech

Customer Journey Mapping means visualizing the path a customer takes—from discovery and engagement to conversion and loyalty. In today’s data-rich and cross-channel ecosystem, MarTech tools elevate this exercise from...

June 16, 2025
PRNewswire
Networking

Netskope Strengthens Relationship with Microsoft to Streamline Data Discovery, Classification, and Protection Across the Enterprise

Netskope, a leader in modern security and networking, today announced expansions to its collaboration with Microsoft to provide comprehensive data security throughout enterprise cloud and AI environments. These include...

June 5, 2025
PRNewswire
Artificial Intelligence

Threekit Launches AI Guided Selling for AV Equipment to Drive High-Quality Leads and Accelerate Sales

Threekit, the leader in AI-powered visual commerce, today announced the launch of its comprehensive AI Suite for AV equipment companies. The platform transforms how buyers discover, configure, and purchase...

June 3, 2025
PRNewswire
Cloud

Salt Illuminate: Revolutionizing API Security with Instant Deployment and Total Visibility

Salt Security, the pioneer in API security, today unveiled Salt Illuminate, a platform that redefines how organizations adopt API security. With its revolutionary self-service onboarding and seamless cloud-native connect capabilities,...

May 29, 2025
PRNewswire
Biotechnology

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson’s Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

Biohaven Ltd. (NYSE: BHVN) (“Biohaven”), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing therapies to treat a broad range of rare and common diseases,...

May 27, 2025
PRNewswire
Biotechnology

Sapience Therapeutics Announces Participation in the Jefferies Global Healthcare Conference

Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, today announced its participation...

May 9, 2025
PRNewswire
Biotechnology

IASO Bio Receives Orphan Drug Designation from the Saudi Food and Drug Authority for Equecabtagene Autoleucel

IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that its self-developed BCMA-targeted CAR-T cell...

April 10, 2025
PRNewswire
Biotechnology

Rivus Pharmaceuticals Expands Leadership Team and Establishes New San Francisco Bay Area Office Ahead of Phase 2 Read-Out in MASH

Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to treating cardiometabolic diseases driven by obesity, today announced the expansion of its leadership team with the appointments of David Grainger, Ph.D.,...